What are Catalyst Pharmaceuticals' share price targets?

5 brokers have issued 1 year price targets for Catalyst Pharmaceuticals' shares. Their CPRX share price targets range from $23.00 to $34.00. On average, they expect the company's share price to reach $26.71 in the next twelve months. This suggests a possible upside of 57.9% from the stock's current price.

Should you buy Catalyst Pharmaceuticals (catalyst) stock?

The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. Catalyst Pharmaceuticals has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Read more about Catalyst Pharmaceuticals' stock forecast and price target.

How far is catalyst pharmaceutical partners stock from the 52-week high?

According to the current price, Catalyst Pharmaceutical Partners is 90.79% away from the 52-week high. What are analysts forecasts for Catalyst Pharmaceutical Partners stock? The 20 analysts offering price forecasts for Catalyst Pharmaceutical Partners have a median target of 25.68, with a high estimate of 34.00 and a low estimate of 15.50.